RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Selina Darling-Reed to Chemokine CCL2

Back to Details
This is a "connection" page, showing publications Selina Darling-Reed has written about Chemokine CCL2.
Selina Darling-Reed
Connection Strength
1.504
Chemokine CCL2
  1. Kanga KJW, Mendonca P, Soliman KFA, Ferguson DT, Darling-Reed SF. Effect of Diallyl Trisulfide on TNF-a-induced CCL2/MCP-1 Release in Genetically Different Triple-negative Breast Cancer Cells. Anticancer Res. 2021 Dec; 41(12):5919-5933.
    View in: PubMed
    Score: 0.673
  2. Bauer D, Redmon N, Mazzio E, Taka E, Reuben JS, Day A, Sadrud-Din S, Flores-Rozas H, Soliman KF, Darling-Reed S. Diallyl disulfide inhibits TNFa induced CCL2 release through MAPK/ERK and NF-Kappa-B signaling. Cytokine. 2015 Sep; 75(1):117-26.
    View in: PubMed
    Score: 0.430
  3. Bauer D, Mazzio E, Soliman KF, Taka E, Oriaku E, Womble T, Darling-Reed S. Diallyl disulfide inhibits TNFa-induced CCL2 release by MDA-MB-231 cells. Anticancer Res. 2014 Jun; 34(6):2763-70.
    View in: PubMed
    Score: 0.400
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support